Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Mary is the bedrock of her family. “She’s the one we all go to,” says her son Eric. “She’s selfless, extremely sweet, very personable—but she can also be very feisty.” So when she returned from an eye ...

The earlier patients with potentially blinding geographic atrophy start treatment with the complement inhibitor pegcetacoplan, the more retinal tissue they retain 4 years later compared with patients ...

Vitamin supplements known to potentially slow the progression of intermediate age-related macular degeneration do not seem to have a similar effect on geographic atrophy, an advanced form of the dry ...

Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 currently approved disease-modifying therapies that restore SMN protein ...

Geographic atrophy (GA), the late stage of age-related macular degeneration (AMD), may lead to vision loss. Here’s what to expect as the condition progresses. About 1 million people in the United ...

ATASCOSA COUNTY, Texas — While the Duke Fire is now 100% contained, neighbors in Bexar and Atascosa counties are coming together to heal and rebuild. “This fire just raged all over back there,” said ...

Spinal bulbar muscular atrophy (SBMA) causes a loss of motor neurons in the spinal cord and brainstem. It mainly affects facial and swallowing muscles and the muscles in the arms and legs. Previously, ...

Researchers from Tokyo Metropolitan University have developed a way to treat aging-related muscular atrophy using regenerative medicine. Conventional methods to implant myoblasts, precursors to muscle ...

Age-related macular degeneration (AMD) is the leading cause of vision loss for people over 65. We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any therapeutics ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In 2024, Healio covered several stories about trials ...